The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA3110355
Max Phase: Preclinical
Molecular Formula: C26H24ClN7O3S
Molecular Weight: 550.04
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: NCc1nnc2c3ccccc3c(-c3ccc(N4CCOCC4)c(NS(=O)(=O)c4ccc(Cl)cc4)c3)nn12
Standard InChI: InChI=1S/C26H24ClN7O3S/c27-18-6-8-19(9-7-18)38(35,36)32-22-15-17(5-10-23(22)33-11-13-37-14-12-33)25-20-3-1-2-4-21(20)26-30-29-24(16-28)34(26)31-25/h1-10,15,32H,11-14,16,28H2
Standard InChI Key: YWKGGSJBLDHNJY-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 550.04Molecular Weight (Monoisotopic): 549.1350AlogP: 3.69#Rotatable Bonds: 6Polar Surface Area: 127.74Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.86CX Basic pKa: 7.26CX LogP: 2.36CX LogD: 2.38Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -2.00
References 1. Fedorov O, Lingard H, Wells C, Monteiro OP, Picaud S, Keates T, Yapp C, Philpott M, Martin SJ, Felletar I, Marsden BD, Filippakopoulos P, Müller S, Knapp S, Brennan PE.. (2014) [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains., 57 (2): [PMID:24313754 ] [10.1021/jm401568s ]